Diagnosis |
Number of cases (n=22) |
Age (years) |
Site |
Size (cm) |
Positive IHC |
Negative IHC |
Epithelioid Sarcoma (Conventional) |
3 |
27 to 47 |
Lower extremities |
5 to 25 |
Vimentin, cytokeratin and CD34 |
S100, CD99, desmin, smooth muscle actin and INI 1 |
Epithelioid Sarcoma (Proximal type) |
2 |
Upper extremities |
Malignant Extrarenal Rhabdoid Tumour |
1 |
35 |
Scapula |
4 |
Vimentin, cytokeratin and CD99 |
S100, desmin, CD34 and INI 1 |
Epithelioid malignant peripheral nerve sheath tumour |
2 |
63 and 50 |
Chest and left leg |
6 and 12 |
S-100 and vimentin |
Cytokeratin, EMA, desmin, CD34, Melan-A and HMB-45 |
Epithelioid Leiomyosarcoma |
1 |
50 |
Left leg |
|
Smooth muscle actin and vimentin |
Cytokeratin, CD34, S100, HMB-45 and CD117 |
Epithelioid angiosarcoma |
3 |
40 to 65 |
Lower extremities |
15 to 25 |
CD31 and factor VIII |
Cytokeratin, EMA and desmin |
Sclerosing epithelioid fibrosarcoma |
1 |
50 |
Left knee |
12 |
Vimentin |
Cytokeratin, EMA, HMB45, desmin and alpha-smooth muscle actin |
Epithelioid myxofibrosarcoma |
3 |
43 to 45 |
Lower extremities |
10 to 20 |
- |
All negative |
Epithelioid gastrointestinal stromal tumour |
2 |
48 and 58 |
Stomach and ileum |
12 and 21 |
CD117 and DOG1 |
Cytokeratin, EMA, HMB45, desmin and alpha-smooth muscle actin |
Clear cell sarcoma |
2 |
17 and 35 |
Left thigh and chest wall |
10 and 6 |
HMB-45, neuron-specific enolase and S-100 |
Cytokeratin, EMA, carcinoembryonic antigen, desmin, Melan-A and smooth muscle actin |
Monophasic synovial sarcoma |
1 |
50 |
Inguinal region |
5 |
Cytokeratin, EMA and vimentin |
Smooth muscle actin, S100 and CD117 |
Malignant perivascular epithelioid cell tumour |
1 |
50 |
Retroperitoneum |
8 |
HMB45, Melan-A and actin |
Cytokeratin, S100 and CD117 |